Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

We are very pleased to inform you that Dr. Marc A. Gauthier has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Early Career Investigator Award, acknowledging his outstanding contributions to our Society...

Dear CBS Members, As you are aware, the COVID-19 pandemic has caused numerous disruptions around the world, and scheduled conferences are being either postponed or canceled...

We are very pleased to inform you that Dr. Paul Santerre has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Lifetime Achievement Award , acknowledging his outstanding contributions to our Society...

CBS is pleased to offer travel awards to assist students and post-doctoral fellows who are CBS members to present their accepted oral or poster abstracts at the 11th World Biomaterials Congress this May in Glasgow, Scotland...

Dental composites have been used for over 50 years as restorative materials. Compared with dental amalgam, these trigger less safety concerns and provide improved aesthetics...

Introduction Elastin-like polypeptides ELPs are a group of widely used synthetic polypeptides used to design stimuli responsive drug delivery systems...

Over 900,000 bone-grafting procedures are performed each year in the USA 1 . Human bone allografts are used in the orthopaedic reconstruction of skeletal defects resulting from traumatic injuries, diseases and revision arthroplasty however, bone allografts have insufficient mechanical properties 2 and graft fracture is a documented clinical failure mode 3 ...

Knee osteoarthritis KOA is the most common osteoarthritis that affects over 10 of Canadians. It occurs in almost all demographics and individuals with injured articular cartilage AC are especially at risk of KOA development...

Despite the extensive development of peptide-based tumor antigen vaccines, the field still faces up enormous challenges from lacking clinical efficacy...